Found: 11
Select item for more details and to access through your institution.
Bioavailability of Cariban<sup>®</sup> Capsules: A Modified-Release Fixed-Dose Combination of Doxylamine and Pyridoxine to Relieve Nausea and Vomiting During Pregnancy.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 185, doi. 10.1007/s40268-023-00425-7
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Parallel-Controlled Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of SCT510 to Bevacizumab (Avastin<sup>®</sup>) in Healthy Chinese Males.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 175, doi. 10.1007/s40268-023-00424-8
- By:
- Publication type:
- Article
N-Acetyl-L-Cysteine Reduces Cervical Carcinogenesis by Promoting Apoptosis.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 165, doi. 10.1007/s40268-023-00423-9
- By:
- Publication type:
- Article
Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 155, doi. 10.1007/s40268-023-00422-w
- By:
- Publication type:
- Article
Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 109, doi. 10.1007/s40268-023-00417-7
- By:
- Publication type:
- Article
Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin's Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 129, doi. 10.1007/s40268-023-00420-y
- By:
- Publication type:
- Article
Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 77, doi. 10.1007/s40268-023-00419-5
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, Three-Period, Three-Sequence Crossover Study.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 121, doi. 10.1007/s40268-023-00418-6
- By:
- Publication type:
- Article
Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 141, doi. 10.1007/s40268-023-00421-x
- By:
- Publication type:
- Article
Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 99, doi. 10.1007/s40268-023-00416-8
- By:
- Publication type:
- Article